FR | ENG
Women's Cardiovascular Healthcare Foundation
Agir pour le Coeur des Femmes
WCHF Logo
logofg

NEWS

Are medications sexist?

Most medicines currently in use were approved based on clinical trials conducted on men. This exposes more women to side effects since the dose prescribe is often too high.

Are medications sexist?

Erving Zucker and his colleagues at University of California Berkeley conducted research in more than 5,000 publications and focused on 86 medications on the U.S. market administered to men and women. At equivalent doses, 76 of them had a higher concentration in women’s blood than in men’s blood, because their metabolism differs, leading to an overdose in women.

The group of researches even found a study showing that a blood thinner medication stayed in women’s blood up to 48 hours, compared to only two hours in men’s blood. This may explain why nearly twice as many women had higher rates of adverse drug reactions than men. Overall, they had adverse reactions twice as often as men. Many drugs are still administered to men and women at the same dose, regardless of their weight and sex, based on the findings of clinical trials conducted in the past mainly on male patients.

Zucker highlighted the fact that for decades, women were excluded from clinical trials based on a principle that’s now recognized as unfounded: that their hormonal fluctuations made them difficult to study. Until the early 1990s, women of childbearing age were also excluded because of medical concerns about risks to the fetus. Today, clinical trials for new drugs include both men and women, but differences in metabolism between the sexes are sometimes overlooked.

A key part of Women’s Cardiovascular Healthcare Foundation’s work is to alert researchers and medical staff about the importance of taking into account the specificities of women’s metabolism when new treatments are developed as well as evaluating any side effects of prescribed treatments during follow-up appointments.

https://bsd.biomedcentral.com/articles/10.1186/s13293-020-00308-5

 
SEE ALSO

Women aged between 24 and 60 are under-represented in cardiovascular prevention check-ups

Women represent around a third of participants, compared with two-thirds of men. And there is a need for more effective screening. These are the conclusions of a study conducted by a team from the cardiology department of the Hôpital Européen Georges-Pompidou AP-HP, Assistance Publique - Hôpitaux [...]

Read more

The right amount of sleep

Good sleep is an asset to good health. The ideal length of sleep is 7 hours a night. Every hour less or more reduces the health benefits. Sleeping seven hours a night reduces the risk of cardiovascular disease by almost 20%, optimizes memory and increases resistance to infection, according to a [...]

Read more

Golf competition and adventure raid to support Agir pour le Cœur des Femmes (Acting for Women's Hearts)

On September 3, the Comité départemental de la Fédération Française de Golf d'Ille-et-Vilaine organized a women's golf competition in aid of Agir pour le Cœur des Femmes, at the Rennes-Saint-Jacques golf course. 66 competitors took part. The participants benefited from a time of [...]

Read more

 Your donation will help improve
prevention at the key moments
of a woman's life
DONATE NOW